Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Marta Delsoglio +447920530707
marta.delsoglio@nutricia.com


Corbin Griffen corbin.griffen@nutricia.com


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS Trial

Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS Trial

Medical Conditions

Malnutrition


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The aim of this study is to evaluate compliance, acceptability, gastrointestinal tolerance, nutrient intake, appetite, nutritional status, and safety of four new ready to drink ONS. This is a prospective, longitudinal, 28-day intervention study with a 1-day baseline period. During the intervention period, patients will receive one of the four ONS for 28 days alongside their routine diet.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Sep 2021 Aug 2026

INTERVENTIONAL

Intervention Type : DIETARY_SUPPLEMENT
Intervention Description : At baseline, the investigating dietitian/nurse will record several measures, including clinical history and symptoms over the previous 24 hours. In addition, patients who are already receiving an ONS will continue their prescribed ONS for 1 day in which their gastrointestinal tolerance, ONS compliance and acceptability will be recorded. All patients will then receive standardised dietary advice in addition to one of the four trial ONS products daily for 28 days. The type of ONS will be agreed with the patient and the investigating dietitian/nurse, and the ONS prescription will be determined on an individual basis by the investigating dietitian/nurse responsible for the patient's nutritional management (1-3 ONS per day; aligned with guidelines set out within the Malnutrition Pathway). The type of ONS prescribed will be the same throughout the 28 days and will be taken orally.

Intervention Arm Group : Dietary supplement (ONS);



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Northumbria Healthcare NHS Foundation Trust
    Newcastle
  • Yeovil District Hospital
    Yeovil
  • NHS Highland
    Inverness
  • Ashford and St Peter's Hospitals NHS Foundation Trust
    Ashford
  • West Walk Surgery
    Bristol
  • Rowden Surgery
    Chippenham
  • Sirona Care & Health
    Clevedon
  • Mountainhall Treatment Centre
    Dumfries
  • Royal Surrey NHS Foundation Trust
    Guildford
  • Preston Hill Surgery
    Harrow
  • Honiton Surgery
    Honiton
  • James Alexander Family Practice
    Hull
  • Airedale NHS Foundation Trust
    Keighley
  • Kings Cross Hospital
    London
  • Norfolk Community Health and Care NHS Trust
    Norwich
  • Glan Clwyd Hospital
    Rhyl
  • Trowbridge Health Centre
    Trowbridge
  • Cowplain Family Practice
    Waterlooville
  • Nottingham University Hospitals NHS Trust
    Nottingham


The study is sponsored by Nutricia UK Ltd




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT05257980
Last updated 24 February 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.